Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CDMO Avid Bioservices, Inc.

停牌 09-02 04:54:57 EDT

12.49

+0.00

0.00%

最高12.49	最低12.49	成交量0.00
今开12.49	昨收12.49	日振幅0.00%
总市值7.99亿	流通市值6.32亿	总股本6,396万
成交额3,832万	换手率0.00%	流通股本5,062万
市净率17.83	ROE-133.29%	每股收益-2.39
52周最高12.51	52周最低5.90	市盈率-5.22
股息0.00	股息收益率0.00	ROA-3.27%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.49,"timestamp":1738702800000,"preClose":12.49,"halted":3,"volume":0,"delay":0,"floatShares":50623090,"shares":63963302,"eps":-2.394638,"marketStatus":"停牌","change":0,"latestTime":"09-02 04:54:54 EDT","open":12.49,"high":12.49,"low":12.49,"amount":38318611.149448,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.394638,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756819800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.49,"volumeRatio":0},"requestUrl":"/m/hq/s/CDMO","defaultTab":"news","newsList":[{"id":"2564827259","title":"普洛药业：CDMO业务逐渐进入收获期 预计将引领公司业绩进入新的增长阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2564827259","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564827259?lang=zh_cn&edition=full","pubTime":"2025-09-02 11:58","pubTimestamp":1756785538,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK0060","BK4139","CDMO","000739","BK0188"],"gpt_icon":0},{"id":"2562034230","title":"创胜集团-B盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562034230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562034230?lang=zh_cn&edition=full","pubTime":"2025-08-28 10:59","pubTimestamp":1756349958,"startTime":"0","endTime":"0","summary":"2025年08月28日早盘10时59分，创胜集团-B股票出现异动，股价大幅下挫5.20%。截至发稿，该股报3.280港元/股，成交量79.3万股，换手率0.18%，振幅8.09%。创胜集团-B股票所在的生物技术行业中，整体跌幅为1.29%。该信息摘要如下：创胜集团-B公布2025年中期业绩，收入271.1万元，同比减少40.6%;期内亏损约1.1亿元，同比收窄17.9%;每股亏损0.27元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828105918976643b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828105918976643b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2562701511","title":"维亚生物盘中异动 早盘股价大跌5.02%报2.270港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562701511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562701511?lang=zh_cn&edition=full","pubTime":"2025-08-28 10:00","pubTimestamp":1756346441,"startTime":"0","endTime":"0","summary":"2025年08月28日早盘10时00分，维亚生物股票出现波动，股价急速下跌5.02%。截至发稿，该股报2.270港元/股，成交量247.8万股，换手率0.12%，振幅5.86%。资金方面，该股资金流入92.5795万港元，流出434.356万港元。最近的财报数据显示，该股实现营业收入21.45亿港元，净利润1.81亿港元，每股收益0.0864港元，毛利7.42亿港元，市盈率26.74倍。维亚生物股票所在的生物技术行业中，整体跌幅为0.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828100041a70038d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828100041a70038d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2562672926","title":"游戏白酒CDMO氯碱行业分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2562672926","media":"明远投研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562672926?lang=zh_cn&edition=full","pubTime":"2025-08-28 01:35","pubTimestamp":1756316109,"startTime":"0","endTime":"0","summary":"CDMO行业上半年营收与利润增长提速，订单趋势良好。大分子CDMO景气度持续修复，双抗、ADC等新分子业务快速成长，小分子业务则保持稳健增长。最后是氯碱行业。当前行业盈利已触底，烧碱和PVC出口稳步增长，后续若需求回升或供给端出现约束，板块弹性可期。可关注一类是具备“烧碱+一体化低成本电石法PVC”的企业，如君正集团、北元集团；另一类是“烧碱+乙烯法PVC”企业，如中泰化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828013607a6ff9065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828013607a6ff9065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2562672135","title":"创胜集团-B盘中异动 股价大跌5.03%报3.590港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562672135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562672135?lang=zh_cn&edition=full","pubTime":"2025-08-27 10:29","pubTimestamp":1756261762,"startTime":"0","endTime":"0","summary":"2025年08月27日早盘10时29分，创胜集团-B股票出现异动，股价急速下挫5.03%。截至发稿，该股报3.590港元/股，成交量61.25万股，换手率0.14%，振幅4.76%。资金方面，该股资金流入44.0225万港元，流出178.571万港元。创胜集团-B股票所在的生物技术行业中，整体跌幅为1.90%。其相关个股中，贝康医疗-B、东曜药业-B、晶泰控股涨幅较大，振幅较大的相关个股有三叶草生物-B、基石药业-B、康诺亚-B，振幅分别为16.30%、12.45%、11.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082710292294ff61a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082710292294ff61a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2561340118","title":"Lifecore Biomedical, Inc.盘中异动 早盘急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561340118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561340118?lang=zh_cn&edition=full","pubTime":"2025-08-22 22:46","pubTimestamp":1755874015,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日22时46分，Lifecore Biomedical, Inc.股票出现异动，股价急速上涨5.12%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.69%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc 是一家完全集成的合同开发和制造组织 ，提供注射器、西林瓶和药筒等复杂无菌注射剂产品的开发、灌装和成品服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822224656a6f5c5d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822224656a6f5c5d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2561425888","title":"研报掘金丨开源证券：普洛药业估值性价比高，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2561425888","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561425888?lang=zh_cn&edition=full","pubTime":"2025-08-22 14:38","pubTimestamp":1755844685,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0060","000739","BK0188","BK4139","161027","BK0239","CDMO"],"gpt_icon":0},{"id":"2561013164","title":"创胜集团-B盘中异动 下午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561013164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561013164?lang=zh_cn&edition=full","pubTime":"2025-08-22 13:38","pubTimestamp":1755841130,"startTime":"0","endTime":"0","summary":"2025年08月22日下午盘13时38分，创胜集团-B股票出现异动，股价快速跳水5.04%。截至发稿，该股报3.770港元/股，成交量166.633万股，换手率0.38%，振幅6.05%。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.16%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822133851a6f4c4d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822133851a6f4c4d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2561641004","title":"创胜集团-B盘中异动 股价大跌5.16%报3.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561641004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561641004?lang=zh_cn&edition=full","pubTime":"2025-08-21 10:56","pubTimestamp":1755744973,"startTime":"0","endTime":"0","summary":"2025年08月21日早盘10时56分，创胜集团-B股票出现异动，股价大幅跳水5.16%。截至发稿，该股报3.860港元/股，成交量129.7万股，换手率0.30%，振幅8.85%。资金方面，该股资金流入135.328万港元，流出350.149万港元。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.69%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082110561397557b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082110561397557b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2561138434","title":"大行评级｜花旗：上调药明生物目标价至40港元 列为CDMO领域首选标的之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2561138434","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561138434?lang=zh_cn&edition=full","pubTime":"2025-08-21 10:42","pubTimestamp":1755744133,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1688375341.USD","LU0327786744.USD","LU0307460666.USD","LU0979878070.USD","LU2456880835.USD","LU0516423174.USD","LU2125154778.USD","LU2360032135.SGD","LU0130517989.USD","LU0417516902.SGD","BK1589","LU2125154935.USD","BK4534","LU0051755006.USD","LU1668664300.SGD","LU0819121731.USD","LU0043850808.USD","LU0516422440.USD","LU1366192091.USD","02269","BK4139","CDMO","LU0181495838.USD","LU0106831901.USD","LU1791807156.HKD","LU1244550221.USD","LU1720050803.USD","LU0130102774.USD","LU1244550577.SGD","LU1880383366.USD","LU0572944931.SGD","LU1794554557.SGD","LU0348735423.USD","LU0823426308.USD","LU2417539215.USD","LU0320765646.SGD","LU1267930227.SGD","LU0052756011.USD","LU0516423091.SGD","LU0052750758.USD","BK1521","LU2236285917.USD","LU0708995583.HKD","SG9999002562.SGD","LU0326950275.SGD","IE00B0JY6N72.USD","LU0648001328.SGD","BK4588","LU0348825331.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2560123605","title":"维亚生物盘中异动 股价大跌5.12%报2.410港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560123605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560123605?lang=zh_cn&edition=full","pubTime":"2025-08-20 09:31","pubTimestamp":1755653492,"startTime":"0","endTime":"0","summary":"2025年08月20日早盘09时31分，维亚生物股票出现异动，股价快速跳水5.12%。截至发稿，该股报2.410港元/股，成交量160.25万股，换手率0.08%，振幅6.69%。资金方面，该股资金流入74.5665万港元，流出279.179万港元。维亚生物股票所在的生物技术行业中，整体跌幅为0.19%。该信息摘要如下：维亚生物科技控股集团宣布，将于2025年8月28日（星期四）召开董事会会议，主要议程包括审议及批准截至2025年6月30日止六个月之中期业绩，同时将考虑建议派付中期股息事宜。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082009313294ee8519&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082009313294ee8519&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2560154924","title":"创胜集团-B盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560154924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560154924?lang=zh_cn&edition=full","pubTime":"2025-08-19 09:37","pubTimestamp":1755567432,"startTime":"0","endTime":"0","summary":"2025年08月19日早盘09时37分，创胜集团-B股票出现异动，股价快速上涨5.33%。截至发稿，该股报4.350港元/股，成交量69.35万股，换手率0.16%，振幅7.26%。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，绿竹生物-B、和誉-B、荣昌生物涨幅较大，振幅较大的相关个股有药明合联、中慧生物-B、创胜集团-B，振幅分别为7.80%、7.29%、7.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819093712a490a461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819093712a490a461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2559867771","title":"研报掘金丨信达证券：药石科技后端CDMO业务增长亮眼，盈利能力存在较大提升空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2559867771","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559867771?lang=zh_cn&edition=full","pubTime":"2025-08-13 15:44","pubTimestamp":1755071072,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["CDMO","BK4139","601059","BK0276","300725","BK4231","BK0229","BK4080","ADC"],"gpt_icon":0},{"id":"2558408076","title":"东曜药业-B(01875)上半年CDMO技术领跑行业 核心产品全球化布局实现突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2558408076","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558408076?lang=zh_cn&edition=full","pubTime":"2025-08-12 21:51","pubTimestamp":1755006691,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东曜药业-B 公布2025年中期业绩，营收约4.89亿元，净利润约406.2万元。得益于公司高效的研发平台，报告期内东曜药业协助客户完成全球首个获批临床的双载荷ADC项目。2025年上半年，该产品已成功通过尼日利亚及巴基斯坦药品监管局的上市批准。后续，东曜药业将负责贝伐珠单抗注射液全球的商业化生产。尼日利亚、巴基斯坦的上市获批开启了东曜药业的国际化商业供应，是公司以国际化质量体系及商业化能力开拓全球市场的又一大突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","CDMO","01875","BK4139"],"gpt_icon":0},{"id":"2557735265","title":"Lifecore Biomedical, Inc.盘中异动 早盘大幅下跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557735265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557735265?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:41","pubTimestamp":1754664088,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时41分，Lifecore Biomedical, Inc.股票出现异动，股价急速下挫5.22%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.88%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808224129a6db3c1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808224129a6db3c1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","CDMO","BK4121","BK4139","LFCR"],"gpt_icon":0},{"id":"2557598901","title":"美国OTC市场Scorpius Holdings, Inc.盘中异动 大幅下挫81.82%报0.002美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557598901?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:29","pubTimestamp":1754587785,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时29分，美国OTC市场Scorpius Holdings, Inc.股票出现异动，股价快速跳水81.82%。截至发稿，该股报0.002美元/股，成交量2.5288万股，换手率0.04%，振幅81.82%。美国OTC市场Scorpius Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。美国OTC市场Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801294594d5f96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801294594d5f96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO","SCPX"],"gpt_icon":0},{"id":"2557309438","title":"Lifecore Biomedical, Inc.盘中异动 急速上涨5.38%报7.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557309438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557309438?lang=zh_cn&edition=full","pubTime":"2025-08-07 01:28","pubTimestamp":1754501295,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日01时28分，Lifecore Biomedical, Inc.股票出现异动，股价大幅上涨5.38%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为2.21%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807012816a6d70485&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807012816a6d70485&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","BK4121","BK4139","LFCR","CDMO"],"gpt_icon":0},{"id":"2557335466","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.01%报7.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557335466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557335466?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:14","pubTimestamp":1754331282,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时14分，Lifecore Biomedical, Inc.股票出现异动，股价大幅上涨5.01%。截至发稿，该股报7.34美元/股，成交量5.8804万股，换手率0.16%，振幅5.72%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.46%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502144294cf6170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502144294cf6170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","BK4121","CDMO","BK4212","BK4139"],"gpt_icon":0},{"id":"2555005265","title":"美国OTC市场Scorpius Holdings, Inc.盘中异动 大幅跳水9.09%报0.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555005265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555005265?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:45","pubTimestamp":1753796704,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时45分，美国OTC市场Scorpius Holdings, Inc.股票出现波动，股价急速下挫9.09%。截至发稿，该股报0.010美元/股，成交量4400股，换手率0.01%，振幅0.00%。美国OTC市场Scorpius Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。美国OTC市场Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214504a469cca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214504a469cca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCPX","CDMO","BK4139"],"gpt_icon":0},{"id":"2552573487","title":"美国OTC市场Scorpius Holdings, Inc.盘中异动 股价大涨46.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552573487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552573487?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:07","pubTimestamp":1752761221,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时07分，美国OTC市场Scorpius Holdings, Inc.股票出现异动，股价急速上涨46.67%。截至发稿，该股报0.088美元/股，成交量11.7489万股，换手率0.19%，振幅46.67%。美国OTC市场Scorpius Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。美国OTC市场Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717220701a6b006be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717220701a6b006be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4139","SCPX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avidbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.2056},{"period":"ytd","weight":0.0113}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avid Bioservices, Inc.最初于1981年6月在美国加州注册成立，并于1996年9月25日在美国特拉华州重新合并。该公司是一家专门的合同开发和制造组织（“CDMO”），提供从工艺开发到当前良好制造实践的全方位服务（“CGMP”）临床和商业制造，专注于从哺乳动物细胞培养中提取生物制药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.645161,"avgChangeRate":0.245054},{"month":2,"riseRate":0.580645,"avgChangeRate":0.056406},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.035156},{"month":4,"riseRate":0.4,"avgChangeRate":-0.032334},{"month":5,"riseRate":0.516129,"avgChangeRate":0.109027},{"month":6,"riseRate":0.419355,"avgChangeRate":0.007765},{"month":7,"riseRate":0.322581,"avgChangeRate":0.039463},{"month":8,"riseRate":0.354839,"avgChangeRate":0.002481},{"month":9,"riseRate":0.387097,"avgChangeRate":-0.046446},{"month":10,"riseRate":0.354839,"avgChangeRate":-0.040707},{"month":11,"riseRate":0.548387,"avgChangeRate":0.073378},{"month":12,"riseRate":0.419355,"avgChangeRate":0.023819}],"exchange":"NASDAQ","name":"Avid Bioservices, Inc.","nameEN":"Avid Bioservices, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avid Bioservices, Inc.,CDMO,Avid Bioservices, Inc.股票,Avid Bioservices, Inc.股票老虎,Avid Bioservices, Inc.股票老虎国际,Avid Bioservices, Inc.行情,Avid Bioservices, Inc.股票行情,Avid Bioservices, Inc.股价,Avid Bioservices, Inc.股市,Avid Bioservices, Inc.股票价格,Avid Bioservices, Inc.股票交易,Avid Bioservices, Inc.股票购买,Avid Bioservices, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}